Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Caspofungin Acetate for Injection Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Caspofungin Acetate for Injection Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 50 mg (base)/Vial
      • 1.3.3 70 mg (base)/Vial
      • 1.3.4 Single Dose Vials
    • 1.4 Market Segment by Application
      • 1.4.1 Global Caspofungin Acetate for Injection Market Share by Application (2019-2025)
      • 1.4.2 Adults Patients
      • 1.4.3 Pediatric Patients
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Caspofungin Acetate for Injection Market Size
      • 2.1.1 Global Caspofungin Acetate for Injection Revenue 2014-2025
      • 2.1.2 Global Caspofungin Acetate for Injection Sales 2014-2025
    • 2.2 Caspofungin Acetate for Injection Growth Rate by Regions
      • 2.2.1 Global Caspofungin Acetate for Injection Sales by Regions 2014-2019
      • 2.2.2 Global Caspofungin Acetate for Injection Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Caspofungin Acetate for Injection Sales by Manufacturers
      • 3.1.1 Caspofungin Acetate for Injection Sales by Manufacturers 2014-2019
      • 3.1.2 Caspofungin Acetate for Injection Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Caspofungin Acetate for Injection Revenue by Manufacturers (2014-2019)
      • 3.2.2 Caspofungin Acetate for Injection Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Caspofungin Acetate for Injection Market Concentration Ratio (CR5 and HHI)
    • 3.3 Caspofungin Acetate for Injection Price by Manufacturers
    • 3.4 Key Manufacturers Caspofungin Acetate for Injection Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Caspofungin Acetate for Injection Market
    • 3.6 Key Manufacturers Caspofungin Acetate for Injection Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 50 mg (base)/Vial Sales and Revenue (2014-2019)
      • 4.1.2 70 mg (base)/Vial Sales and Revenue (2014-2019)
      • 4.1.3 Single Dose Vials Sales and Revenue (2014-2019)
    • 4.2 Global Caspofungin Acetate for Injection Sales Market Share by Type
    • 4.3 Global Caspofungin Acetate for Injection Revenue Market Share by Type
    • 4.4 Caspofungin Acetate for Injection Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Caspofungin Acetate for Injection Sales by Application

    6 United States

    • 6.1 United States Caspofungin Acetate for Injection Breakdown Data by Company
    • 6.2 United States Caspofungin Acetate for Injection Breakdown Data by Type
    • 6.3 United States Caspofungin Acetate for Injection Breakdown Data by Application

    7 European Union

    • 7.1 European Union Caspofungin Acetate for Injection Breakdown Data by Company
    • 7.2 European Union Caspofungin Acetate for Injection Breakdown Data by Type
    • 7.3 European Union Caspofungin Acetate for Injection Breakdown Data by Application

    8 China

    • 8.1 China Caspofungin Acetate for Injection Breakdown Data by Company
    • 8.2 China Caspofungin Acetate for Injection Breakdown Data by Type
    • 8.3 China Caspofungin Acetate for Injection Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Caspofungin Acetate for Injection Breakdown Data by Company
    • 9.2 Rest of World Caspofungin Acetate for Injection Breakdown Data by Type
    • 9.3 Rest of World Caspofungin Acetate for Injection Breakdown Data by Application
    • 9.4 Rest of World Caspofungin Acetate for Injection Breakdown Data by Countries
      • 9.4.1 Rest of World Caspofungin Acetate for Injection Sales by Countries
      • 9.4.2 Rest of World Caspofungin Acetate for Injection Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Merck Sharp & Dohme Ltd
      • 10.1.1 Merck Sharp & Dohme Ltd Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Caspofungin Acetate for Injection
      • 10.1.4 Caspofungin Acetate for Injection Product Introduction
      • 10.1.5 Merck Sharp & Dohme Ltd Recent Development
    • 10.2 Hengrui Pharma
      • 10.2.1 Hengrui Pharma Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Caspofungin Acetate for Injection
      • 10.2.4 Caspofungin Acetate for Injection Product Introduction
      • 10.2.5 Hengrui Pharma Recent Development
    • 10.3 Mylan
      • 10.3.1 Mylan Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Caspofungin Acetate for Injection
      • 10.3.4 Caspofungin Acetate for Injection Product Introduction
      • 10.3.5 Mylan Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Caspofungin Acetate for Injection Sales Channels
      • 11.2.2 Caspofungin Acetate for Injection Distributors
    • 11.3 Caspofungin Acetate for Injection Customers

    12 Market Forecast

    • 12.1 Global Caspofungin Acetate for Injection Sales and Revenue Forecast 2019-2025
    • 12.2 Global Caspofungin Acetate for Injection Sales Forecast by Type
    • 12.3 Global Caspofungin Acetate for Injection Sales Forecast by Application
    • 12.4 Caspofungin Acetate for Injection Forecast by Regions
      • 12.4.1 Global Caspofungin Acetate for Injection Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Caspofungin Acetate for Injection Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Caspofungin acetate for injection is an echinocandin antifungal indicated in adults and pediatric patients (3 months of age and older) for:
       Empirical therapy for presumed fungal infections in febrile, neutropenic patients.
       Treatment of candidemia and the following Candida infections: intra-abdominal abscesses, peritonitis and pleural space infections.
       Treatment of esophageal candidiasis.
       Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies.
      In 2019, the market size of Caspofungin Acetate for Injection is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Caspofungin Acetate for Injection.

      This report studies the global market size of Caspofungin Acetate for Injection, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Caspofungin Acetate for Injection sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Merck Sharp & Dohme Ltd
      Hengrui Pharma
      Mylan
      ...

      Market Segment by Product Type
      50 mg (base)/Vial
      70 mg (base)/Vial
      Single Dose Vials

      Market Segment by Application
      Adults Patients
      Pediatric Patients

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Caspofungin Acetate for Injection status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Caspofungin Acetate for Injection manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Caspofungin Acetate for Injection are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now